# Quadrise positioning itself to be one of the key decarbonisation solution providers

- Link: https://www.directorstalkinterviews.com/quadrise-positioning-itself-to-be-one-of-the-key-decarbonisation-solution-providers/4121136099
- Published: 2023-10-02T07:27:00+01:00
- Author: Amilia Stone

**[Quadrise plc](https://www.directorstalkinterviews.com/company/quadrise-plc/qed.l)**(
LON:QED), the supplier of MSAR^(®) and bioMSAR™ emulsion technology and fuels, providing
innovative lower cost and lower carbon alternatives to fuel oil and biofuels, has
announced its audited final results for the year ended 30 June 2023.

The Company also gives notice that the Company’s Annual General Meeting will be 
held at 12 noon on 27 November 2023 at the Park Plaza County Hall Hotel, 1 Addington
Street, London, SE1 7RY.

**Operational Summary:**

·    **Marine** – Following the completion of key preparatory steps for the Proof-
of-Concept and Letter Of No Objection (“LONO”) commercial trials on bioMSAR™ with
MSC Shipmanagement during the year, Quadrise intends to conclude agreements with
project stakeholders, which include a major global trading company, as soon as possible.
Quadrise equipment will be installed and commissioned at the bunker terminal site
ahead of the commercial-scale Proof-of-Concept and LONO trials on bioMSAR™, which
are expected to commence in Q1 2024 provided the relevant permits are received in
time.

·    **Morocco** -The industrial demonstration test at the client site in Morocco
is now expected to be completed in October 2023, following the installation and 
commissioning of a replacement pump and maintenance of the client’s commercial unit
during September. The client remains supportive of the Company’s efforts to progress
the commercial trial. Upon successful conclusion of the trial, the parties will 
enter into discussions for potential commercial supply, in addition to concluding
agreements for testing at other client sites as required.

·    **Utah –** Valkor Technologies LLC (“Valkor”) has informed the Company that
it expects to conclude project ﬁnancing relating to their primary project site at
in Utah in Q4 2023. Provided a minimum of US$15 million is successfully raised, 
Valkor will pay Quadrise US$1.0 million under the terms of the Site License and 
Supply Agreement signed in June 2023. The Agreement was amended in August 2023 in
order to remove conditionality with regard to Valkor’s receipt of drilling permits.
A further US$0.5 million is due from Valkor upon delivery of an MSAR^(®) Manufacturing
Unit to the project site in Utah, again, subject to Valkor’s receipt of the minimum
project financing.

·    **bioMSAR™ –** In June 2023, Quadrise signed a Joint Development Agreement 
with BTG Bioliquids to investigate the use of their propriety pyrolysis bio-oil (
FPBO) as an alternative biofuel feedstock for bioMSAR™. In addition, Quadrise successfully
produced stable blends of bioMSAR™ containing up to 40% of Vertoro’s crude sugar
oil (CSO™) at pilot scale at the Company’s research facility. This demonstrated 
improved engine efficiency, and lower NOx and particulate emissions upon combustion
when compared to conventional diesel. Further testing is also ongoing with other
biofuels suppliers.

**Financial Summary:**

·   Loss after tax of £3.1m (2022: £2.6m), of which of £1.7m (2022: £1.5m) is attributable
to production and development costs and £1.3m (2022: £1.4m) relates to administrative
and corporate expenses.

·   Total assets of £5.0m as at 30 June 2023 (2022: £8.0m).

·   Cash balances as at 30 June 2023 of £1.3m (2022: £4.4m). An additional £1.94m(
gross) was raised in July 2023 via a placing and open offer.

·   Cumulative tax losses of £62.1m (2020: £60.0m) potentially available for set-
off against any future profits.

> **Jason Miles, Chief Executive Officer of Quadrise, commented:**
> _“The decarbonisation of the energy sector continues to advance during a period
> of escalating energy costs, increasing legislation and pressure to reduce emissions
> and control global warming._
> _Against this background, Quadrise is positioning itself to be one of the key 
> decarbonisation solution providers in this rapidly changing global energy market._
> _Whilst progress across each of the Company’s key projects during the period has
> been at a slower pace than we had initially envisaged, important milestones for
> each are now nearing. Agreements covering our commercial vessel trial with MSC
> and other stakeholders are expected to be signed in Q4 2023, with the trial itself
> planned to commence in Q1 2024. Supply of our first MSAR^(®) site license and 
> equipment to Valkor in Utah is expected in Q4 2023, pending successful conclusion
> of Valkor’s project financing. Following the installation of an alternative pump,
> the MSAR^(®) and bioMSAR™ commercial trial in Morocco is due to conclude before
> the end of October 2023._
> _We continue to invest and collaborate in research and development to enhance 
> our IP portfolio and future opportunities, evidenced by our patent applications
> and the continuing advancement of bioMSAR™ and bioMSAR™ Zero with a growing number
> of partners in the renewable fuel sector._
> _We look forward to the important period ahead during which we expect to make 
> significant progress in commercialising our innovative fuel technology.”_

**Notice of Annual General Meeting**

The Company’s Annual General Meeting (“AGM”) will be held at 12 noon on 27 November
2023 at the Park Plaza County Hall Hotel, 1 Addington Street, London, SE1 7RY.

**Chairman’s Statement**

The cost of energy and the transition to secure sustainable fuels continue to be
top priorities for governments, businesses and communities. During the year ended
30 June 2023, Quadrise has continued to position itself as a provider of innovative
decarbonisation solutions and the Board remains confident in both the quality of
the Company’s solutions and the commercial opportunities that they provide.

In July 2023, the Company announced that it had raised gross proceeds of £1.94 million
via a placing of new ordinary shares in the Company and subsequent open offer to
qualifying shareholders at an issue price of 1.25 pence per share. The funds raised
will, together with receipts from contracted but conditional payments in respect
of the Company’s Utah project with Valkor, enable the Company to continue to finance
its projects through to mid-2024 and thereby to achieve further milestones that 
add shareholder value.

The successful completion of the fundraising under difficult market conditions demonstrated
the continuing confidence of new and existing investors in the potential of our 
technology and its applicability to real-world problems. The result is that the 
current financial year is pivotal for Quadrise, with our key objectives being:

·    To progress business in North America, building on a bridgehead to be established
in Utah.

·    To contract sources of heavy residues and glycerine for product supply outside
North America.

·    To be ready to scale-up our marine business following the planned completion
of the trial with MSC.

Our near-term strategy remains to focus on the key projects in Morocco, Utah and
with MSC, which represent the most efficient use of our financial resources and 
provide the fastest and most material pathways to commercialisation. Important milestones
are expected to be achieved in Q4 2023 in each of these key projects:

·    Following the signing of a Site License & Supply Agreement with Valkor Technologies
LLC in June 2023, commercial revenues are now expected from Valkor subject to successful
completion of their heavy oil project financing. This is a critical milestone in
attracting new customers, investors and strategic partners. We now look forward 
to the commencement of Valkor’s pilot drilling operations ahead of the winter season.

·    The trial with our customer in Morocco is anticipated to resume in early October
2023 after a series of technical delays caused by feed pump problems, with commercial
discussions then to take place following confirmation of a successful trial.

·    We also look forward to being able to update the market on the next steps with
respect to fuel supply logistics for the long-awaited on-board trial of bioMSAR™
with MSC, with the finalisation of trial agreements expected in Q4 2023. The 4,000-
hour trial is planned to start in Q1 2024.

Looking further ahead, we continue to develop the next generation of bioMSAR™ fuel
and energy delivery technologies, with the goal of producing a commercially competitive
net-zero product before 2030.

The year ended 30 June 2023 could be characterised as one of continued strategic
and operational progress, but without a breakthrough. Each of our projects has several
moving parts, and the management task is significant in bringing the Company to 
an inflexion point. However, we hope to see the results of progress to date come
to fruition during the final quarter of 2023. The Board remains active in evaluating
strategic initiatives that would de-risk and/or facilitate the delivery of our key
objectives set out above, such as M&A activity, joint ventures or other strategic
partnerships. As I stated last year, our ambitions for the business are limited 
more by the availability of financial and operational resources than by the scale
of the significant opportunities that the Company can address.

The Board remains committed in its determination for the Company to deliver on its
strategic objectives and together with management, we look forward to driving the
business into commercial revenues and generating value for our shareholders, whom
I thank for their continued support and engagement throughout the year.

**Results for the Year**

The consolidated after-tax loss for the year to 30 June 2023 was £3.1m (2022: £2.6m),
with the loss per share for the year increasing to 0.22p from 0.18p in 2022. Production
and development costs of £1.7m (2022: £1.5m) comprise the costs of the Group’s R&
D facility (‘QRF’ in Essex), its operational staff and consultants, and ongoing 
bioMSAR™ and MSAR^(®) development costs. These costs are largely related to fixed
costs with the increase due to bioMSAR™ development and testing costs.

Administration expenses of £1.3m (2022: £1.4m), comprise the Group’s corporate staff
and directors’ costs, professional advisor fees, PR/IR costs and head office costs.

At 30 June 2023, the Group had total assets of £5.0m (2022: £8.0m). The most significant
balances were cash of £1.3m (2022: £4.4m), intangible assets of £2.9m (2022: £2.9m),
and property, plant and equipment of £0.4m (2022: £0.4m). The Group has tax losses
arising in the UK of approximately £62.0m (2020: £60.0m) that are potentially available
to be carried forward against any future profits.

**Andy Morrison**

Non-executive Chairman

29 September 2023

**Chief Executive’s Statement**

**Introduction**

The global energy industry faces mounting pressure to reduce carbon emissions whilst
delivering practical and cost-efficient energy solutions to consumers. In recent
times, escalating energy prices have emerged as significant contributors to global
inflation, exacerbated by the ongoing Ukraine conflict and Russian sanctions. Simultaneously,
there is a crucial global goal to halve greenhouse gas (“GHG”) emissions by 2050,
a target set by the IPCC to mitigate the severe consequences of climate change.

**Addressing the Maritime Decarbonisation Challenge**

The shipping sector is responsible for roughly 3% of global GHG emissions. The sector
is under increasing scrutiny from European regulators who are encouraging maritime
operators to explore lower-carbon and eventually net-zero alternatives. These include
longer-term options such as green hydrogen, ammonia, and methanol, with each of 
these demanding substantial investments and posing logistical and safety challenges.
While several lower-carbon and potentially net-zero solutions are in development,
these are not yet ready for widespread adoption. Implementation will require significant
investment, either in retrofitting existing fleets or the building of new vessels
and the logistical challenges of delivery should not be underestimated in the context
of currently reduced global ship building capacity.

**Revolutionary Quadrise Technology**

Our patented Quadrise technology offers a practical and cost-effective path for 
operators in the marine, industrial, and power sectors to decarbonise, reduce energy
costs, and lower associated emissions safely. MSAR^(®) reduces fuel consumption 
in diesel engines by up to 10% and simultaneously lowers GHG emissions by the same
margin. By incorporating renewable glycerine to produce the economical bioMSAR™,
we can further reduce GHG emissions by over 20%. The Quadrise solutions are readily
available, utilising existing infrastructure to achieve cost savings and GHG reduction.
bioMSAR™ outperforms LNG and FAME marine fuel blends in terms of lower CO_(2) emissions
per unit of energy. Other bioMSAR™ benefits include its water dispersibility, improved
safety, and biodegradability.

**Immediate and Future Deployment**

Our technology is ready for rapid deployment, delivering immediate benefits as we
transition towards net-zero fuel solutions, which may become mandatory as early 
as 2030. To seize this opportunity, we have established an R&D strategy, leveraging
our innovative and adaptable technology. We are collaborating with fellow innovators
in the sustainable fuel sector to expand our portfolio of lower-cost, renewable,
and abundant biofuel components. As an example, we are formulating a bioMSAR™ blend
with Vertoro BV, producers of a crude sugar oil (“CSO™”). Diesel engine testing 
of this blend at Aquafuel is set to conclude in Q4 2023. Additionally, Quadrise 
has entered into a Joint Development Agreement with BTG Bioliquids to explore the
use of their ‘FPBO’ biofuel, derived from agricultural and sawmill waste, alongside
other related net-zero R&D activities.

**Ongoing Projects**

Our core projects encompass the marine, upstream, and industrial sectors, with further
projects in the pipeline for downstream and power plant applications. Our current
focus is on demonstrating MSAR^(®) and bioMSAR™ technology at a commercial scale,
progressing these opportunities into commercial supply agreements.

The demand for scalable and certified low or zero-emission shipping services is 
evident in the historic tender recently issued by an alliance of freight buyers 
including Amazon, IKEA, Philips and over 20 other major global companies. The RfP(
Request for Proposal) launched by ZEMBA (Zero Emission Maritime Buyers Alliance)
seeks bids with sufficient capacity to move 600,000 containers over 3 years on ships
that offer 90% reduction in GHG emissions compared to traditional fossil fuels. 
This is further evidence of the demand for our technology solutions and the concerted
industry effort to accelerate decarbonisation in shipping.

**MSC** – A framework agreement with MSC Shipmanagement (“MSC”) was signed in July
2022 to test and trial both of our economical, cleaner marine fuel and biofuel alternatives
on their container vessels. Quadrise is excited to be collaborating with MSC to 
decarbonise the largest container ship fleet in the world as they lead the way in
advancing the marine sector’s transition towards a net-zero future.

A number of preparatory steps have been completed by stakeholders prior to commencing
the Letter Of No Objection (“LONO”) fuel trials of both bioMSAR™ and MSAR^(®) on
board the MSC Leandra:

·    Wärtsilä Services of Switzerland carried out optical combustion and engine 
wear tests on bioMSAR™ in December 2022.

·    The emulsion fuel booster unit was inspected, upgraded where necessary, and
tested in readiness for use.

·    The vessel was fully inspected by MSC and installed with equipment designed
to reduce emissions and improve vessel efﬁciency.

·    A hazard identiﬁcation and operability workshop was recently completed involving
MSC, Quadrise, Wärtsilä and Lloyds Register using the framework developed for the
prior use of MSAR^(®) on the main 2-stroke engine, when the vessel was owned by 
Maersk.

Quadrise is progressing the fuel production and supply activities necessary for 
the above commercial trials, with the intention of concluding agreements with project
stakeholders, which include a major global trading company, as soon as possible.
Following the installation and commissioning of Quadrise equipment at the bunker
terminal site, the intention is then to commence commercial-scale Proof-of-Concept
and LONO trials on bioMSAR™ in Q1 2024 provided the relevant permits are received
in time.

Once the initial MSAR^(®) or bioMSAR™ fuel has been loaded and the on-board systems
commissioned, the vessel will be bunkering and burning bioMSAR™ through the initial
Proof-of-Concept testing phase, followed by the LONO trial, which is currently expected
to be of 4,000-hour duration.

In addition to progressing this opportunity with MSC, the Company continues to assess
strategic means and/or partnerships with the intention of accelerating the commercialisation
of both bioMSAR™ and MSAR^(®) for marine applications.

**Utah –** Our project in Utah, USA with Valkor Technologies LLC (“Valkor”) involves
the use of MSAR^(®) technology to emulsify low-sulphur heavy oil. Valkor has interests
in multiple projects at the Asphalt Ridge site with anticipated oil deposits of 
billions of barrels. Valkor plan to recover heavy oil from oil-sand and sub-surface
oil deposits at their Primary Project Site (“PPS”) at Asphalt Ridge using production
methods that mitigate greenhouse gas emissions. Crucially, by using Quadrise technology,
the viscosity of the extracted heavy oil is reduced, facilitating transportation
whilst avoiding the use of costly diluents or excessive heat in the supply chain.
The resulting MSAR^(®) or bioMSAR™ produced is an alternative to very low sulphur
fuel oil (<0.5%S “VLSFO”) or biofuels used in multiple industrial, power and marine
fuel applications. Oil samples from the PPS supplied by Valkor were successfully
converted to both MSAR^(®) and bioMSAR™ by our RDI team in 2022.

Valkor is leading activities for the award of drilling permits at Asphalt Ridge 
as follows:

·     Valkor undertook successful exploration drilling and optimisation of oil sands
processing technologies during 2022.

·     In December 2022, and on behalf of their project partners Heavy Sweet Oil 
LLC (“HSO”) and AC Oil LLC (“ACO”), Valkor submitted a pilot drilling development
plan to the State of Utah’s Board of Oil, Gas and Mining (the “OGM Board”) and the
permits for this were awarded subject to technical approval by the Utah Division
of Oil, Gas and Mining (the “Division”).

·     Once technical approval is received (expected by Valkor to be in early October
2023), Valkor plan to commence pilot drilling at the PPS in October 2023 and in 
parallel submit Underground Injection Control permit applications for the subsequent
injection of steam for enhanced heavy oil recovery.

·     Using standard well spacing of 40 acres, Valkor expect to be able to drill
up to 12 wells under the pilot development plan approved by the OGM Board in December
2022 and managed by the Division, upon receipt of technical approvals as stated 
above.

·     In addition to the pilot drilling programme, Valkor, on behalf of project 
sponsors HSO and ACO, applied for approval of a Unitisation Plan. This allows for
up to 119 wells to be drilled at Asphalt Ridge, using a reduced well spacing of 
2.5 acres. The OGM Board met in August 2023 to review the Plan, and this was, for
the moment, declined. Their view was that without a producing well in place, there
was insufficient evidence of heavy oil properties and sub-surface locations within
the planned area to support the Plan as submitted. 

·     It is important to note that the OGM Board’s decision on the Unitisation plan
does not impact Valkor’s intention to drill the pilot wells conditionally granted
by the Board in December 2022. Pilot well drilling would then potentially support
a further PPS Unitisation Plan application in due course. Valkor are also managing
conventional oil sands projects for other clients that are not subject to associated
approvals for drilling or Unitisation.

·     Valkor are now actively seeking minimum project financing of US$15 million
which is required in order to progress their activities at the PPS planned for Q4
2023.

In June 2023, Quadrise signed a Site License and Supply Agreement (“SLA”) with Valkor.
Under the SLA, Quadrise has granted Valkor the exclusive right and licence to use
its technology at the PPS and to market the fuel on a non-exclusive basis from Utah.
In exchange, Valkor will pay Quadrise US$1.0 million subject to receipt by Valkor
of a minimum US$15 million of PPS project ﬁnancing referred to above, which Valkor
expect to receive in Q4 2023.

Further conditionality in the SLA, relating to the award by the Division of the 
drilling and underground injection permits for the PPS was waived by Valkor in August
2023, based on the positive progress already made on these activities. Also under
the SLA, Valkor will pay Quadrise a further US$0.5 million upon delivery of an MSAR
Manufacturing Unit (“MMU”) to the PPS, again, subject to Valkor’s receipt of the
minimum project financing.

The Company is in regular contact with Valkor, who remain confident of receipt of
the minimum project financing of US$15 million in the near term, however, until 
this is received there remains a risk that the aggregate US$1.5m due to Quadrise
is significantly delayed or not received at all.

Following Valkor’s receipt of the MMU, Quadrise will provide engineering and other
support services for a minimum of two years in exchange for a quarterly retainer
of US$75,000. Valkor may then choose to purchase the technology and MMU for a further
US$1.0 million.

A non-binding Heads of Agreement has also been entered into between the parties 
which sets out the basis on which Quadrise and Valkor will seek to agree a conditionally
exclusive Sub-License Agreement to be granted to Valkor covering the state of Utah,
as well as the terms on which the resulting net proﬁt generated will be shared between
Quadrise and Valkor.

**Morocco** – In June 2022, QIL signed a new Material Transfer & Cooperation Agreement
with its client in Morocco, a major chemicals company, under which QIL will manufacture
trial quantities of MSAR^(®) and bioMSAR™ for the purpose of an industrial demonstration
test at the client’s ‘Site-B’ facility. QIL will then provide the client with a 
written report on the efﬁcacy of using MSAR^(®) and bioMSAR™. Provided the client-
speciﬁed deliverables regarding performance and product quality are met, the parties
will enter into discussions for a potential commercial supply of MSAR^(®) and/or
bioMSAR™. In parallel with preparations for the site demonstration tests, Quadrise
has completed a technical and economic feasibility study for a potential additional
industrial demonstration test at a second site of the client. This additional industrial
demonstration test will be subject to future agreement, once conﬁrmed.

Following the signature of the new Agreement, volumes of MSAR^(®) and bioMSAR™ were
produced by Quadrise at a site in Europe and shipped to Morocco in Q4 2022. Due 
to the process of clearing a new fuel through Moroccan customs, the commencement
of the MSAR^(®) demonstration test was subject to delays, with 60mt of MSAR^(®) 
and 10mt of bioMSAR™ arriving at Site B in late February 2023. Following the completion
of the site engineering set up, and ﬁnalisation of the client’s production schedule,
the trial formally commenced in May 2023.

Cold start-up of the client’s commercial unit was carried out and the initial unit
combustion warm-up sequence was tested using MSAR^(®) fuel. Whilst running at 100%
load a mechanical component in the pumping and heating unit (“PHU”) failed progressively.
This reduced the available unit load achievable from the burner, and it became impossible
to complete the testing during May as originally planned. The parties agreed to 
pause the trial so that the client could complete their scheduled production run,
and the respective pump could be replaced. Unfortunately, it was not possible to
complete the test at full load due to a progressive decline in replacement fuel 
pump performance on several occasions during August 2023, indicating a design issue
with the pump units at high pressure.

A replacement pump of alternative design from a new supplier has been expedited 
to Morocco, installed in the PHU, and commissioned by the Quadrise team. The trial
is now expected to be completed in October 2023, following maintenance of the client’s
commercial unit where the testing was carried out in September. The client remains
supportive of the Company’s efforts to resolve this final issue and progress the
commercial trial at the next available opportunity.

Upon successful conclusion of the trial, the parties will enter discussions for 
potential commercial supply, in addition to concluding agreements for testing at
other client sites as required. Commercial supply will be dependent on the Company
being able to source appropriately situated and priced feedstock.

**Other projects** – QIL signed a Letter of Intent in Q1 2023 with a central American
power provider outlining our mutual intent for a commercial test of MSAR^(®) and
bioMSAR™ at the provider’s power plant, with the conclusion of a Test Agreement 
and site trial being the precursors for entry into a Fuel Supply Agreement. Discussions
are ongoing and we originally expected agreements to be ﬁnalised during Q4’23. However,
the region is experiencing a significant and extended drought that is forcing the
electricity sector into an ongoing emergency situation as hydroelectric dams are
generating less power, and all other power plants are running at full capacity in
order to close the gap. Therefore, the opportunity to conduct a site trial is delayed.
Together with our local agents, we continue to explore other opportunities in the
region. Efforts continue to progress activities in Mexico with the state oil company(
Pemex) and utility operators.

In December 2022, Quadrise received and successfully commissioned our prototype 
5 tonne per hour emulsion system that will be used for the production of MSAR^(®)
and bioMSAR™ fuels for site trials and potential ‘blend-on-board’ (“BoB”) testing
on marine vessels. BoB involves installation of an MSAR^(®) Manufacturing Unit (“
MMU”) and associated equipment on board a marine vessel, with MSAR^(®) and bioMSAR
™ produced on board. This allows vessels additional routing ﬂexibility as well as
simplifying the MSAR^(®) and bioMSAR™ supply chain. A joint patent application with
Nouryon was filed in April 2023 covering BoB. Quadrise has received enquiries from
a number of marine operators regarding BoB which are in the scoping phase of project
development and BoB is also under investigation as part of the MSC framework agreement.
QIL is currently in discussions with a refinery in Asia who are interested in using
this unit to conduct a refinery refuelling trial using MSAR^(®) in advance of a 
potential commercial agreement.

**bioMSAR™ and bioMSAR™ Zero development –** During the period, Quadrise has successfully
tested bioMSAR™ produced using glycerine sourced from a variety of European suppliers
in advance of commercial vessel trials with MSC.  In parallel the Company has been
investigating alternative feedstocks to glycerine for bioMSAR™ and oil-soluble biofuels
that would allow the development of a commercial net-zero version, ‘bioMSAR™ Zero’,
by 2030.  As part of this work, following the June 2023 signature of a Joint Development
Agreement with BTG Bioliquids, their propriety pyrolysis bio-oils (FPBO) and related
sugars have been tested at the Company’s research facility QRF, with successful 
bioMSAR™ blends being produced using the sugars. In addition, Quadrise successfully
produced stable blends of bioMSAR™ containing up to 40% of Vertoro’s crude sugar
oil (CSO™) at pilot scale.  Engine tests of CSO bioMSAR™ demonstrated improved engine
efficiency, as well as lower NOx and visible particulate emissions during use when
compared to conventional diesel. A joint patent application with Vertoro was filed
in August 2023 covering CSO bioMSAR™.  Further testing will now take place including
the Vertoro CSO and BTG Bioliquids sugars feedstocks in bioMSAR™ fuels at reputable
third-party testing facilities.

# Outlook

In March 2023, the Group rebranded as Quadrise plc to better align with our focus
on energy decarbonisation and carbon mitigation. Our annual [Sustainability](https://www.directorstalkinterviews.com/sustainability-green-stocks-news)
Report, launched in November 2022, provides valuable insights into our environmental
contributions and commitment to create a net-zero fuel by 2030.

Environmental considerations and emissions regulations are becoming ever more prominent
in driving the business case for MSAR^(®) and bioMSAR™ technology. In the United
States, the Inﬂation Reduction Act has created a favourable environment for energy
decarbonisation technologies which we look forward to capitalising upon with our
partner, Valkor.

The introduction and implementation of environmental regulations, particularly in
Europe, is expected to increase biofuel use in our target sectors. Shipping is now
included in the EU ETS and Fit-for-55 regulations, which are expected to increase
the use of marine biofuels from 2024 for most vessels operating within or near EU
waters. Revenues raised in the sector via the ETS are to be reinvested into an Innovation
Fund reserved for sustainable shipping, the protection of maritime habitats and 
for funding programmes to decarbonise the maritime sector. Additionally, subsidies
are still available for renewable waste-based biofuel feedstocks such as glycerine
that should enhance the attractiveness of bioMSAR™ against competing biofuels in
certain bunker locations. Market conditions and trends therefore provide a favourable
environment for Quadrise to progress its contract discussions and business development
activities on all fronts.

During 2022-23, we have seen energy security, climate change, and fuel costs rise
to the top of the policy agenda for governments and businesses alike, and the need
for solutions such as ours has never been more vital. The positioning of Quadrise
as an energy decarbonisation enabler is an important statement of intent to progress
licence agreements and commercial-scale trials which are expected to lead to supply
contracts and commercial revenues from MSAR^(®) and bioMSAR™.

The energy sector is experiencing significant shifts, with energy security, climate
change, and fuel costs taking centre stage. Quadrise remains dedicated to its mission
and appreciates the ongoing support of our shareholders in seeking to shape a cleaner
future.

**Jason Miles**

Chief Executive Officer

29 September 2023

Share on:
